Phase I trials are clinical trials, i.e., human trials.  The website and the MD&A show that a Phase 3 COVID-19 study is planned.  Wideout has the trials mixed up but RVX might apply for an EUA as he notes -- perhaps after the Phase 2 trial?  I don't know.

EUA is mentioned in the Eversana press release: "....a partnership to support planned commercialization of apabetalone....as Emergency Use Authorization and/or a New Drug Application or equivalent is issued or approved...."

The study description at clinicaltrials.gov shows the study as....

Phase 2
Phase 3

I'm not sure why it shows "Phase 3".  Is that included to give them the option of morphing it into a Phase 3 trial if the Phase 2 is successful?  I don't know.